Cost-effectiveness of FDG-PET

Completed

• Conditions: Oncologic Patients

• Registration Number: NCT01438164
• Lead Sponsor: University of Sao Paulo

Brief Summary

Evaluation of cost-effectiveness of FDG-PET for the public health system in Brazil.

Detailed Description

To provide detailed information about cost and effectiveness of FDG-PET in multiple oncological diseases, such as Lymphoma, lung cancer and esophageal cancer.

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2005-06
• Primary Completion: 2010-06
• Status Verified: 2011-09
• Study Completion: 2011-09
• Study First Submitted: 2011-09-20
• Study First Submitted QC: 2011-09-20
• Last Update Submitted: 2011-09-20
• Study First Posted: 2011-09-21
• Last Update Posted: 2011-09-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Cancer

Read More

Exclusion Criteria

• Other malignancy
• Uncontrolled Diabetes
• Pregnancy

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified